Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.
Fernández-Rodríguez C, Rodríguez-Sevilla JJ, Fernández-Ibarrondo L, Sánchez-González B, Gibert J, Bento L, García JF, Sancho JM, Diez-Feijóo R, Camacho L, García-Retortillo M, Gimeno E, Colomo L, Gutiérrez A, Bellosillo B, Salar A. Fernández-Rodríguez C, et al. Blood Adv. 2022 Jan 11;6(1):82-86. doi: 10.1182/bloodadvances.2021005316. Blood Adv. 2022. PMID: 34649275 Free PMC article.
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martín L, Prieto M, Gutiérrez ML, Suárez E, Gómez Rubio M, López J, Castillo P, Rodríguez M, Zozaya JM, Simón MA, Morano LE, Calleja JL, Yébenes M, Esteban R. Buti M, et al. PLoS One. 2017 Sep 12;12(9):e0184550. doi: 10.1371/journal.pone.0184550. eCollection 2017. PLoS One. 2017. PMID: 28898281 Free PMC article. Clinical Trial.
On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.
Broquetas T, Hernandez JJ, Garcia-Retortillo M, Canillas L, Puigvehí M, Cañete N, Coll S, Viu A, Garrido E, Mico M, Bessa X, Carrión JA. Broquetas T, et al. Dig Liver Dis. 2022 Aug;54(8):1044-1051. doi: 10.1016/j.dld.2021.12.017. Epub 2022 Jan 19. Dig Liver Dis. 2022. PMID: 35063365 Free article.
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).
Jiménez C, Ventura-Cots M, Sala M, Calafat M, Garcia-Retortillo M, Cirera I, Cañete N, Soriano G, Poca M, Simón-Talero M, Altamirano J, Lucey M, Garcia-Tsao G, Brown RS Jr, Schwabe RF, Verna EC, Schnabl B, Bosques-Padilla F, Mathurin P, Caballería J, Louvet A, Shawcross DL, Abraldes JG, Genescà J, Bataller R, Vargas V. Jiménez C, et al. Liver Int. 2022 May;42(5):1109-1120. doi: 10.1111/liv.15207. Epub 2022 Mar 7. Liver Int. 2022. PMID: 35220659 Free PMC article.
Clinical Value of Thyrotropin Receptor Antibodies for the Differential Diagnosis of Interferon Induced Thyroiditis.
Benaiges D, Garcia-Retortillo M, Mas A, Cañete N, Broquetas T, Puigvehi M, Chillarón JJ, Flores-Le Roux JA, Sagarra E, Cabrero B, Zaffalon D, Solà R, Pedro-Botet J, Carrión JA. Benaiges D, et al. Exp Clin Endocrinol Diabetes. 2016 Jan;124(1):39-44. doi: 10.1055/s-0035-1565071. Epub 2015 Nov 17. Exp Clin Endocrinol Diabetes. 2016. PMID: 26575116
A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
Carrión JA, Gonzalez-Colominas E, García-Retortillo M, Cañete N, Cirera I, Coll S, Giménez MD, Márquez C, Martin-Escudero V, Castellví P, Navinés R, Castaño JR, Galeras JA, Salas E, Bory F, Martín-Santos R, Solà R. Carrión JA, et al. J Hepatol. 2013 Nov;59(5):926-33. doi: 10.1016/j.jhep.2013.06.019. Epub 2013 Jun 26. J Hepatol. 2013. PMID: 23811030 Clinical Trial.
53 results